RecruitingPhase 2NCT07463183
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Sponsor: Merck Sharp & Dohme LLC
Inverness, FL · Miami, FL · Orlando, FL · +8 more sites